TCS, HDFCBANK, SBI Liquid Fund (G)
Medplus Health Services Ltd.
Medplus Health Servi
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 14 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 10 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 03 02 2023 | Quarterly Results |
| 11 05 2023 | Inter alia, to consider for approval of Members through Postal Ballot for the following business by way of Special Resolution: i. Approval for extending benefits of Employees Stock Option Plan 2023. to the employees of its Subsidiary Companies; and ii. Alteration of Articles of Association of the Company in relation to retain the Nomination Rights of the Promoters/Investors as per existing Articles of Association of the Company |
| 25 05 2023 | Audited Results |
| 01 08 2023 | Quarterly Results |
| 07 08 2023 | Quarterly Results (Revised) |
| 05 10 2023 | Inter alia, to consider and approve the Proposal for raising of funds by the Company |
| 11 10 2023 | Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alio, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alio, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and/ or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. The Board, would further convene an Extra-ordinary General Meeting or postal ballot to obtain the approval of shareholders for the above proposal, once approved by the Board. |
| 26 10 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results (Revised) |
| 02 02 2024 | Quarterly Results |
| 21 02 2024 | Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023. |
| 28 05 2024 | Audited Results |
| 12 11 2024 | Quarterly Results |
| 31 01 2025 | Quarterly Results |
| 27 05 2025 | Audited Results |
News
No News data available
